SG97918A1 - A novel drug delivery system: formulation for fat-soluble drugs - Google Patents
A novel drug delivery system: formulation for fat-soluble drugsInfo
- Publication number
- SG97918A1 SG97918A1 SG200004450A SG200004450A SG97918A1 SG 97918 A1 SG97918 A1 SG 97918A1 SG 200004450 A SG200004450 A SG 200004450A SG 200004450 A SG200004450 A SG 200004450A SG 97918 A1 SG97918 A1 SG 97918A1
- Authority
- SG
- Singapore
- Prior art keywords
- fat
- formulation
- delivery system
- drug delivery
- soluble drugs
- Prior art date
Links
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI20002572 MY120392A (en) | 2000-06-08 | 2000-06-08 | A novel drug delivery system : formulation for fat-soluble drugs |
US09/612,434 US6596306B1 (en) | 2000-07-07 | 2000-07-07 | Drug delivery system:formulation for fat-soluble drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
SG97918A1 true SG97918A1 (en) | 2003-08-20 |
Family
ID=26641506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200004450A SG97918A1 (en) | 2000-06-08 | 2000-07-26 | A novel drug delivery system: formulation for fat-soluble drugs |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN1165290C (en) |
HK (1) | HK1043944A1 (en) |
SG (1) | SG97918A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100361656C (en) * | 2004-08-27 | 2008-01-16 | 石药集团中奇制药技术(石家庄)有限公司 | Butylbenzene phthalein self emulsifying releasing medicine system, preparation method and application |
CN1660064B (en) * | 2004-12-28 | 2010-09-29 | 中山大学 | Nage lieqin self-emulsifying system for releasing medicine |
MY182652A (en) * | 2014-11-25 | 2021-01-27 | Kl Kepong Oleomas Sdn Bhd | Formulation for effective tocotrienol delivery |
CN106667920A (en) * | 2016-12-29 | 2017-05-17 | 陕西科技大学 | Vitamin A nanoparticle and preparation method thereof |
-
2000
- 2000-07-26 SG SG200004450A patent/SG97918A1/en unknown
-
2001
- 2001-01-23 CN CNB011113383A patent/CN1165290C/en not_active Expired - Lifetime
-
2002
- 2002-07-15 HK HK02105207A patent/HK1043944A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1043944A1 (en) | 2002-10-04 |
CN1165290C (en) | 2004-09-08 |
CN1339297A (en) | 2002-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1091732A4 (en) | Effervescent drug delivery system for oral administration | |
IL180450A0 (en) | Pharmaceutical formulations comprising a waterinsoluble complex for sustained drug delivery | |
AU8781798A (en) | Sustained release drug delivery system suitable for oral administration | |
AU2001273376A1 (en) | Drug delivery device for animals | |
AU2001235009A1 (en) | Drug delivery apparatus | |
AU2123200A (en) | Drug delivery device | |
AU4985600A (en) | Drug delivery device | |
PT1239831E (en) | Improved pharmaceutical compositions for poorly soluble drugs | |
HUP0001914A3 (en) | Biocompatible compounds for pharmaceutical drug delivery systems | |
NZ513700A (en) | Oral drug delivery system | |
AU4947100A (en) | Drug delivery device | |
HK1077523A1 (en) | Proliposomal drug delivery system | |
AU9223098A (en) | Dosage form comprising means for changing drug delivery shape | |
HRPK20010706B1 (en) | Tolperison-containing, pharmaceutical preparation for oral administration | |
EP1221926A4 (en) | Pharmaceutical formulations containing poorly soluble drug substances | |
IL137559A0 (en) | Transdermal drug delivery system | |
AU3055099A (en) | A pharmaceutical formulation for nasal administration | |
SG97918A1 (en) | A novel drug delivery system: formulation for fat-soluble drugs | |
GB0029843D0 (en) | Drug delivery system | |
EP1438087A4 (en) | System for administering a drug delivery device | |
AU2002210580A1 (en) | Drug delivery system | |
GB2405094B (en) | Pharmaceutical composition for controlled drug delivery system | |
GB0030138D0 (en) | Drug delivery system | |
AU2001280085A1 (en) | Oral osmotic controlled drug delivery system for a sparingly soluble drug | |
AUPR146700A0 (en) | Drug delivery system |